Calm drug could keep critically ill patients off breathing tubes
NCT ID NCT06259565
Summary
This large international trial is testing if a calming drug called dexmedetomidine can help critically ill adults who are struggling with a non-invasive breathing mask. The goal is to see if the drug improves tolerance of the mask, reducing the need for patients to be put on an invasive breathing machine with a tube. The study will enroll 846 adults in intensive care who are agitated or intolerant of their breathing mask support.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-INVASIVE VENTILATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brockville General Hospital
NOT_YET_RECRUITINGBrockville, Ontario, K6V 1S8, Canada
Contact
Contact Email: •••••@•••••
-
Fraser Health Authority
NOT_YET_RECRUITINGSurrey, British Columbia, V3T 0H1, Canada
Contact Email: •••••@•••••
Contact
-
Juravinski Hospital and Cancer Centre
NOT_YET_RECRUITINGHamilton, Ontario, L8V 1C3, Canada
Contact
Contact Email: •••••@•••••
-
North York General Hospital
NOT_YET_RECRUITINGToronto, Ontario, M2K 1E1, Canada
Contact
Contact Email: •••••@•••••
-
Sinai Health System
NOT_YET_RECRUITINGToronto, Ontario, M5G 1X5, Canada
Contact
Contact Email: •••••@•••••
-
St. Joseph's Healthcare Hamilton
RECRUITINGHamilton, Ontario, L8N 4A6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.